Drug detox for Lantana — substance-specific protocols, not one-size-fits-all.

For Lantana, Hypoluxo Island, and Manalapan residents, RECO Island is the closest small-census, physician-led medical detox with in-house residential transition — 11 miles south down Federal Highway, roughly 18 minutes. Detox protocols are substance-specific rather than one-size-fits-all: COWS-guided buprenorphine induction for opioids, long-half-life conversion and slow taper for benzodiazepines, and supportive medical management for stimulant withdrawal. Detox rolls directly into residential on the same campus with the same clinical team — no waitlist, no third-party handoff — and MAT continues through residential and community handoff rather than stopping at discharge.

Lantana and Hypoluxo Island occupy the narrow band of barrier island and mainland between Delray Beach and West Palm Beach, roughly 11 miles and 18 minutes from RECO Island’s Delray Beach campus down Federal Highway — slightly less via A1A when traffic is light. For residents of Manalapan, Ocean Ridge, and Old Town Lantana, physician-led medical detox does not require leaving the immediate region or crossing county lines.

Substance-specific withdrawal protocols

Opioid, benzodiazepine, and stimulant withdrawal are three clinically distinct syndromes, and running a single protocol across all of them is bad medicine. Opioid withdrawal from heroin, fentanyl, or prescription analgesics is intensely uncomfortable but rarely medically dangerous on its own. The RECO Island medical team uses COWS-guided buprenorphine induction — typically initiated once COWS reaches 12 or higher — to convert the withdrawal experience from acute crisis to a controlled taper within hours. Methadone induction is reserved for cases in which buprenorphine is contraindicated, most commonly high-dose fentanyl exposure where precipitated withdrawal risk is elevated.

Benzodiazepine withdrawal shares clinical territory with alcohol withdrawal — untreated, it can produce autonomic instability, seizures, and death. The protocol converts short-half-life agents such as alprazolam or lorazepam to a long-half-life equivalent, typically clonazepam or diazepam, then tapers over weeks rather than days. Compressing a benzodiazepine detox into a five-day window to fit a program schedule is a common outpatient error, and one this program explicitly does not make. Progress is tracked with CIWA-Ar scoring at defined intervals through the taper.

Stimulant withdrawal from cocaine or methamphetamine has no specific pharmacologic antidote. The clinical picture is depression, anhedonia, hypersomnia, and intense craving. Supportive care — sleep restoration, nutritional rehabilitation, and short-course adjuncts such as bupropion, mirtazapine, or low-dose quetiapine for severe insomnia — addresses the actual syndrome rather than pretending there is a benzodiazepine-style algorithm to run.

Polysubstance detox and the sequencing decision

The presenting picture in 2026 is rarely single-substance. Concurrent use of alcohol, benzodiazepines, opioids, and stimulants — frequently combined with cannabis and unregulated kratom or gabapentin — is now the norm, and it changes detox planning meaningfully. The sequencing principle is straightforward: manage the potentially life-threatening syndromes first.

In practice that means initiating a CIWA-guided alcohol taper or benzodiazepine long-agent conversion on admission, starting buprenorphine induction for opioid use disorder concurrently once precipitated withdrawal risk has been evaluated, and treating stimulant withdrawal supportively rather than sedating through it. Every polysubstance detox plan is documented in the chart before the first dose, with substance-specific taper endpoints, MAT initiation targets, comorbid diagnoses, and any prior seizure history flagged for the on-call physician.

The alternative — running a uniform protocol and letting the pharmacology sort itself out — produces the prolonged withdrawal, breakthrough seizures, and against-medical-advice discharges that fill nearby emergency departments. RECO Island’s census is deliberately kept small so that each polysubstance case receives the individualized planning the clinical picture requires rather than being fit to a standing order set.

Medical comorbidity is the norm, not the exception

For a substantial proportion of clients entering detox, the admission physical is the first medical encounter in years. Chronic substance use produces predictable comorbidities that outpatient primary care has often not been in a position to address: hepatitis C from injection or intranasal use, cardiomyopathy and coronary disease from long stimulant exposure, malnutrition and refeeding risk in advanced alcohol use disorder, undiagnosed type 2 diabetes, untreated hypertension, chronic pain self-medicated with the very substances in question, and sleep-disordered breathing that will not resolve without evaluation.

Admission workup at RECO Island is not a checkbox. Baseline labs include CBC, comprehensive metabolic panel, liver function, hepatitis panel, HIV screening, urine drug screen, and pregnancy testing where applicable. Cardiac evaluation with ECG is standard before any QT-prolonging medication is initiated — relevant when using methadone, quetiapine, or ondansetron within the detox order set. Nutritional assessment identifies clients at refeeding risk who need slow reintroduction with thiamine and electrolyte replacement.

Medical conditions identified on admission are managed concurrently by the on-site medical team through detox and residential rather than deferred to a discharge referral that a substantial number of clients would never attend. Detox is a clinical window; treating only the withdrawal wastes it.

The handoff into residential and MAT continuation

Medical detox produces safe withdrawal. It does not produce recovery. Detox alone — without immediate transition into structured residential or PHP-level care, and without medication for addiction treatment where indicated — has a 90-day relapse rate that clinical literature places well above 90% for opioid use disorder. The drug detox program at RECO Island exists specifically to close that gap.

Detox at the Delray Beach campus feeds directly into residential treatment on the same property, with the same clinicians, without a third-party handoff. The residential bed is held during detox — no waitlist, no discharge between levels — and clinical continuity means the psychiatric medications initiated during detox continue uninterrupted rather than being restarted from scratch. That includes sertraline or another SSRI for underlying depression, buspirone for generalized anxiety not requiring benzodiazepine coverage, low-dose quetiapine for detox-emergent insomnia, and mirtazapine for appetite and sleep support in post-stimulant withdrawal.

MAT continuation is standard of care rather than an option. Buprenorphine for opioid use disorder is continued through residential and stepped down to community maintenance at discharge. Naltrexone — oral or long-acting injectable — is initiated after an appropriate opioid-free window for OUD or AUD. Discharging a client off MAT is a clinical decision made against evidence, not a default.

What admission from Lantana looks like

Admission from Lantana, Hypoluxo Island, Manalapan, or Ocean Ridge begins with a phone call to the RECO Island admissions team, who complete an initial clinical screen: substances used, last use, quantity and duration, prior withdrawal history including any seizure history, current medications, psychiatric history, and immediate safety concerns. Insurance verification runs concurrently on the same call.

Transport from Lantana is 18 minutes south down Federal Highway or a similar drive on A1A. Clients who need transport rather than family driving are picked up directly by the RECO Island transport team at no additional charge. Assessment on arrival includes a physician history and physical, ASAM Criteria placement across all six dimensions, PHQ-9 and GAD-7 baseline psychiatric screens with additional instruments added where the history indicates, COWS scoring for opioid users, and CIWA-Ar for alcohol or benzodiazepine users.

Detox length runs 5 to 10 days for most substances and longer for benzodiazepine tapers. Transition to residential occurs directly on the same campus without a discharge between levels.

Insurance and admissions from Lantana

RECO Island is in-network with the major commercial carriers held across Palm Beach County — Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield plans. Verification of benefits for detox and residential coverage typically returns on the initial admissions call, with specific detail on the deductible, coinsurance, out-of-pocket maximum, and any prior authorization the carrier requires.

For clients without commercial coverage, self-pay and financing options are quoted openly with actual pricing rather than “call for details” evasions. Florida Medicaid and Medicare are not contracted at the residential level of care; clients whose coverage is limited to those programs are referred to appropriate in-network facilities rather than admitted to a program their coverage will not fund.

Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.